These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19342969)

  • 1. Conditioning vaccination site with irradiated MIP-3alpha-transfected tumor cells enhances efficacy of dendritic cell-based cancer vaccine.
    Shih NY; Yang HY; Cheng HT; Hung YM; Yao YC; Zhu YH; Wu YC; Liu KJ
    J Immunother; 2009 May; 32(4):363-9. PubMed ID: 19342969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of MIP-1alpha-recruited dendritic cells on preestablished solid and metastatic tumors.
    Cao Q; Jin Y; Jin M; He S; Gu Q; He S; Qiu Y; Ge H; Yoneyama H; Zhang Y
    Cancer Lett; 2010 Sep; 295(1):17-26. PubMed ID: 20202744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
    Yei S; Bartholomew RM; Pezzoli P; Gutierrez A; Gouveia E; Bassett D; Soo Hoo W; Carlo DJ
    Gene Ther; 2002 Oct; 9(19):1302-11. PubMed ID: 12224013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses.
    Weigel BJ; Panoskaltsis-Mortari A; Diers M; Garcia M; Lees C; Krieg AM; Chen W; Blazar BR
    Exp Hematol; 2006 Oct; 34(10):1403-12. PubMed ID: 16982333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of MIP-3alpha gene to the tumor following radiation therapy boosts anti-tumor immunity in a murine model of lung carcinoma.
    Zhu B; Zou L; Cheng X; Lin Z; Duan Y; Wu Y; Zhou F; Chen Z
    Immunol Lett; 2006 Mar; 103(2):101-7. PubMed ID: 16257060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity].
    Tan XH; Wan YH
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):399-403. PubMed ID: 17456382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours.
    Chandy AG; Nurkkala M; Josefsson A; Eriksson K
    Vaccine; 2007 Aug; 25(32):6037-46. PubMed ID: 17629599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of dendritic cell infiltration with active crypt inflammation in ulcerative colitis.
    Watanabe S; Yamakawa M; Hiroaki T; Kawata S; Kimura O
    Clin Immunol; 2007 Mar; 122(3):288-97. PubMed ID: 17178254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous administration of MIP-1alpha with intra-tumor injection of P. acnes shows potent anti-tumor effect.
    Nakano A; Yoneyama H; Ueha S; Kitabatake M; Ishikawa S; Kawase I; Sugiyama H; Matsushima K
    Int Immunopharmacol; 2007 Jun; 7(6):845-57. PubMed ID: 17466918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S; Lee JB; Lee GK; Chang J
    Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microencapsulation of tumor lysates and live cell engineering with MIP-3α as an effective vaccine.
    Huang FY; Huang FR; Chen B; Liu Q; Wang H; Zhou SL; Zhao HG; Huang YH; Lin YY; Tan GH
    Biomaterials; 2015; 53():554-65. PubMed ID: 25890751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells.
    Koppenhagen FJ; Küpcü Z; Wallner G; Crommelin DJ; Wagner E; Storm G; Kircheis R
    Clin Cancer Res; 1998 Aug; 4(8):1881-6. PubMed ID: 9717815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinations with dendritic cells primed with apoptotic tumor cells can elicit preventive antitumor immunity in a poorly immunogenic animal model of squamous cell carcinoma.
    Jeong HS; Lee H; Ko Y; Son YI
    Laryngoscope; 2007 Sep; 117(9):1588-93. PubMed ID: 17597627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity.
    Bonnotte B; Crittenden M; Larmonier N; Gough M; Vile RG
    J Immunol; 2004 Oct; 173(8):4929-35. PubMed ID: 15470034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of dendritic cells with interferon-gamma-inducible protein-10 gene to enhance vaccine potency.
    Kang TH; Bae HC; Kim SH; Seo SH; Son SW; Choi EY; Seong SY; Kim TW
    J Gene Med; 2009 Oct; 11(10):889-98. PubMed ID: 19618483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIP-3alpha and MIP-1alpha rapidly mobilize dendritic cell precursors into the peripheral blood.
    He S; Cao Q; Yoneyama H; Ge H; Zhang Y; Zhang Y
    J Leukoc Biol; 2008 Dec; 84(6):1549-56. PubMed ID: 18791167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue.
    Mac Keon S; Gazzaniga S; Mallerman J; Bravo AI; Mordoh J; Wainstok R
    Vaccine; 2010 Nov; 28(51):8162-8. PubMed ID: 20937314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive and therapeutic antitumor effect of tumor vaccine composed of CpG ODN class C and irradiated tumor cells is triggered through the APCs and activation of CTLs.
    Novaković S; Stegel V; Kopitar A; Ihan A; Novaković BJ
    Vaccine; 2007 Nov; 25(49):8241-56. PubMed ID: 17980936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with an immature dendritic cell-targeting vaccine supplemented with IFN-α and an inhibitor of DNA methylation markedly enhances survival in a murine melanoma model.
    Gordy JT; Luo K; Kapoor A; Kim ES; Ayeh SK; Karakousis PC; Markham RB
    Cancer Immunol Immunother; 2020 Apr; 69(4):569-580. PubMed ID: 31980915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.